Stephen Lam

Corporate Officer/Principal presso Omnitura Therapeutics, Inc.

Consumer Services

Health Technology

Health Services

Profilo

Stephen Lam is a Professor at the University of British Columbia and the Chief Medical Officer-Pulmonology at Omnitura Therapeutics, Inc. He previously worked as the Chairman at BC Cancer Agency, Advisor at the University of Colorado and the National Cancer Institute, and as an Advisor at the US Department of Health & Human Services.
He also served as a Governor at The American College of Financial Services and as an Advisor at The University of Texas Southwestern Medical Center.

Posizioni attive di Stephen Lam

Società	Posizione	Inizio
Omnitura Therapeutics, Inc. Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA.	Corporate Officer/Principal	-
University of British Columbia	Corporate Officer/Principal	18/09/2009

Tutte le posizioni attive di Stephen Lam

Precedenti posizioni note di Stephen Lam

Società	Posizione	Fine
The American College of Financial Services	Direttore/Membro del Consiglio	-
The University of Colorado	Corporate Officer/Principal	-
The University of Texas Southwestern Medical Center	Corporate Officer/Principal	-
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Corporate Officer/Principal	-
US Department of Health & Human Services (DC)	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Stephen Lam

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Stephen Lam

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Omnitura Therapeutics, Inc. Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA.	Health Technology
BC Cancer Agency BC Cancer Agency Medical/Nursing ServicesHealth Services BC Cancer Agency provides healthcare services. The firm serves for hereditary cancer, indigenous cancer care, interpreters, and psychiatry. Its services include assessment and follow-up library, nutrition services, pain and symptom management, patient and family counselling, PET functional imaging, primary care, screening programs, and speech-language pathology. The company was founded on November 5, 1938 and is headquartered in Vancouver, Canada.	Health Services
US Department of Health & Human Services (DC)	Government
National Cancer Institute National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.	Miscellaneous

Vedi le connessioni aziendali